87407-53-2

Upstream product

• 104846-62-0 3(S)-tert-butyldimethylsilyloxy-9,10-secoergosta-5,7(E),10⁽¹⁹⁾,22(E)-tetraene 
• 141411-00-9 (20S)-Des-A,B-22-(acetoxy)-23,24-dinorcholane-8-one 
• 69454-87-1 (3β,20S)-3-<(tert-butyldimethylsilyl)oxy>pregn-5-ene-20-carboxylic acidmethyl ester 
• 99518-39-5 3β-hydroxy-22,23-dinor-5,7-choladienic acid methyl ester 
• 97903-24-7 (5Z,7E)-(3S,20S)-3-hydroxy-9,10-seco-5,7,10⁽¹⁹⁾pregnatriene-20-carboxylic acid methyl ester 
• 50-14-6 Calciferol 
• 228113-80-2 C₂₈H₄₈O₂Si 
• 87407-51-0 C₂₈H₄₈O₂Si 

Downstream Products

• 1258066-55-5 AB₄₇ 

Relevant academic research and scientific papers

Probing the structural requirements for vitamin D3 inhibition of the hedgehog signaling pathway

A structure-activity relationship study to elucidate the structural basis for hedgehog (Hh) signaling inhibition by vitamin D3 (VD3) was performed. Functional and non-functional regions of VD3 and VD2 were obtained through straightforward synthetic means

22-HALOACETOXY-HOMOPREGNACALCIFEROL ANALOGS AND THEIR USES

This invention discloses 22-haloacetoxy-homopregnacalciferol analogs and specifically 22-bromoacetoxy-homopregnacalciferol and pharmaceutical uses therefor. This compound exhibits relatively little calcemic activity and does not promote cellular different